This website describes Equisculpt Novem Fund — the brand name of Novem Prime Incorporated VCC Sub-Fund, a sub-fund of the umbrella vehicle Equisculpt Novem Capital VCC, a Mauritius variable capital company holding a Global Business Licence issued by the Financial Services Commission, Mauritius. It is provided for information only and does not constitute an offer, solicitation or investment advice.
The fund is available exclusively to eligible investors who meet applicable qualification requirements, on the basis of its confidential offering documents. It is not open to residents of India under the Indian FEMA and SEBI FPI frameworks, and nothing on this site is directed at any person in a jurisdiction where such distribution would be unlawful.
Past performance — including the track record of related entities — is not indicative of future results. Investment involves risk, including possible loss of capital.
The registrations behind the fund, the basis of every performance figure shown on this website, and the restrictions that apply — consolidated in one place.
“Equisculpt Novem Fund” is the brand name of Novem Prime Incorporated VCC Sub-Fund, registered with the Registrar of Companies, Mauritius (No. C234119), a sub-fund of the umbrella vehicle Equisculpt Novem Capital VCC, which holds a Global Business Licence (No. GB26205965) issued by the Financial Services Commission, Mauritius, and is authorised as a VCC fund under the Variable Capital Companies Act 2022. India access is through the SEBI FPI Category I route. A licence or registration is not an endorsement by any regulator of the fund’s performance or prospects.
All performance figures on this website relate to the advisory activity of the Equisculpt Ventures group, a related entity — not to Equisculpt Novem Fund, which is recently constituted and has no operating history of its own. Anchor IPO figures are verifiable against public NSE Emerge and BSE SME filings; entry is the allotment price and exit the realised market exit within the stated window; returns are gross of fees and taxes. The group blended XIRR is money-weighted across all group strategies, manager-computed and not independently verified. Marks on open positions are indicative values as at the dates stated, are not independently verified, may not be realisable, and are not returns. Past performance is not indicative of future results.
Target corpus, target gross IRR and similar figures are objectives under the fund’s FSC-filed investment policy. They are not projections, forecasts or guarantees. There is no assurance any objective will be achieved.
An investment in the fund involves significant risk, including illiquidity, valuation uncertainty on unlisted positions, currency movement, small-cap volatility and the possible loss of the entire amount invested. The fund’s risk page describes fifteen risk families and their controls; the complete risk factors are set out in the confidential offering documents, which alone govern any investment.
The fund’s official net asset value is computed by the independent administrator (KFS, Mauritius) on the fund’s quarterly valuation cycle. Between official valuations the manager may publish indicative NAV estimates for transparency; these are unaudited, are clearly labelled wherever shown, may be revised without notice, and create no entitlement. All subscriptions and redemptions are processed exclusively at the administrator’s official NAV as at the relevant dealing date, which may differ from any indicative estimate previously displayed. No claim may be founded on an indicative figure.
The fund is not available to residents of India under the Indian FEMA framework, and nothing on this website is directed at any person in a jurisdiction where such distribution would be unlawful. Eligibility is determined case by case following KYC/AML and suitability verification. This website is information, not an offer or solicitation; any offer is made only through the fund’s confidential offering documents.
Novem Insights content is prepared for information only, is not investment, legal or tax advice, and relies on public sources believed reliable but not independently verified. Views are those of the named authors as at the publication date and may change without notice.
Questions about these disclosures: ir@novemfund.com. See also the legal notice, privacy policy and terms of use.